Advanced Hands-On Training Course

Developed by Subject Matter Experts at CMaT, Georgia Institute of Technology for graduates of the Workforce Development in Biomanufacturing - The Fundamentals Virtual Course. 

Learn from experts about critical laboratory safety and gain the practical skills necessary to work competently in GLP and GMP-like laboratories*. This five-day, hands-on training teaches you the techniques central to cell and gene therapy manufacturing, including aseptic cell culture techniques, large-scale cell manufacturing, analytical techniques and product characterization, cell banking and documentation using GLP/GMP-like best practices.

Email Raymond@ISCTglobal.org or shalu.suri@bme.gatech.edu to register.

*It is not meant to replace company-specific training.

COURSE CONTENT

LEARNING OUTCOMES:

• Distinguish hazards among the new standardized pictograms and gain knowledge on hazardous chemicals on the Safety Data Sheet (SDS). 

• Apply aseptic techniques and good laboratory practices to work in cell culture and GLP/GMP-like labs. 

• Develop an understanding of the conditions to culture and maintain high-quality therapeutic cells. 

• Perform key steps to initiate, maintain, and expand cells in culture. 

• Understand key steps in the downstream processing of human cells, including harvesting and cryopreservation. 

• Evaluate the quality and sterility of cell products. 

• Apply GLP/GMP-like guidelines to document cell products. 

Price (USD)

“A well-trained, readily available, diverse workforce is crucial to the success of the emerging cell and gene therapy industry, especially given its highly specialized skill sets, GMP and regulatory requirements, and complex manufacturing and supply chain infrastructure.

Our partnership with ISCT brings the largest cell manufacturing research and education consortium together with the largest global cell & gene therapy society to deliver critically needed workforce training for CGT. Together, we hope to develop a robust, on-demand, client-centric training platform for industry and clinical manufacturers.”
-Krishnendu Roy, Robert A. Milton Chair, CMaT

“ISCT has long identified and taken measures to alleviate the skills shortages across the cell and gene therapy sector. ISCT has run a range of courses across the CGT sector, including forming our ISCT Early-Stage Professionals (ESP) Committee, responsible for our extensive Mentoring Program. Despite these efforts, growth in the CGT sector continues to outpace the professionals entering. This is a major issue for the sector that could become critical in the near future."
-Bruce Levine, Immediate-Past President, ISCT